Search results
Jump to navigation
Jump to search
Page title matches
- {{Image|Warfarin structure.jpg|right|200px|Structure of Warfarin.}} '''Warfarin''' (IUPAC name52 KB (7,136 words) - 22:53, 6 April 2014
- #redirect [[Warfarin]]22 bytes (2 words) - 12:03, 20 January 2009
- 145 bytes (20 words) - 19:56, 1 May 2008
- 119 bytes (15 words) - 15:27, 20 May 2008
- *Warfarin Plus *Warfarin Q641 bytes (63 words) - 16:18, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:03, 20 January 2009
- 12 bytes (1 word) - 12:10, 22 January 2008
- 486 bytes (57 words) - 22:34, 10 March 2010
- 632 bytes (92 words) - 17:12, 27 August 2008
Page text matches
- ...rphism may cause [[warfarin]]-sensitivity. VKORC1 missense mutations are [[warfarin]]-resistant.<ref>{{OMIM|608547}}</ref>311 bytes (36 words) - 02:03, 7 October 2013
- #redirect [[Warfarin]]22 bytes (2 words) - 12:01, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 11:57, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:03, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 11:59, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:01, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 11:58, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:03, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 11:59, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:01, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 11:58, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:03, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:00, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:01, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 11:58, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:03, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:00, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:02, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 11:58, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:03, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:00, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 11:50, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:02, 20 January 2009
- #REDIRECT [[Warfarin]]22 bytes (2 words) - 12:32, 22 January 2008
- #redirect [[Warfarin]]22 bytes (2 words) - 11:58, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:03, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:00, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 11:56, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:02, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 11:58, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:04, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:00, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 11:56, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:02, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 11:59, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:04, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:00, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 11:56, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:02, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 11:59, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:05, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:01, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 11:57, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:02, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 11:59, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:01, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 11:57, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 12:03, 20 January 2009
- #redirect [[Warfarin]]22 bytes (2 words) - 11:59, 20 January 2009
- *Warfarin Plus *Warfarin Q641 bytes (63 words) - 16:18, 20 January 2009
- ***[[Warfarin]]157 bytes (11 words) - 04:36, 10 June 2008
- An [[anticoagulant]] that inhibits factor Xa, orally administered like [[warfarin]] but not requiring the same close safety monitoring; approved only in Euro221 bytes (28 words) - 11:21, 6 December 2009
- ...thrombin time (PT) ratio, used as a standard for monitoring the effects of warfarin.158 bytes (22 words) - 19:39, 7 September 2009
- {{r|Warfarin}}142 bytes (16 words) - 23:05, 17 February 2009
- {{r|Warfarin||**}}325 bytes (35 words) - 10:59, 23 August 2010
- {{r|Warfarin||**}}151 bytes (16 words) - 17:22, 27 August 2008
- {{r|Warfarin||**}}215 bytes (22 words) - 17:24, 27 August 2008
- {{r|Warfarin||**}}263 bytes (27 words) - 00:30, 3 March 2010
- {{r|warfarin}}125 bytes (13 words) - 18:46, 7 July 2011
- {{r|Warfarin}}508 bytes (63 words) - 14:01, 24 January 2011
- ...singer CM, Wan F, Yang YX, Hennessy S| title=Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk. | journal=Am J Med | year= 20102 KB (227 words) - 07:30, 11 May 2010
- {{r|Warfarin}}476 bytes (63 words) - 19:46, 11 January 2010
- {{r|Warfarin}}520 bytes (65 words) - 19:29, 11 January 2010
- {{r|Warfarin}}608 bytes (78 words) - 19:29, 11 January 2010
- {{r|Warfarin}}614 bytes (84 words) - 21:33, 11 January 2010
- {{r|Warfarin}}616 bytes (75 words) - 16:49, 11 January 2010
- {{r|Warfarin}}640 bytes (81 words) - 16:17, 11 January 2010
- {{r|Warfarin}}926 bytes (114 words) - 15:48, 11 January 2010
- ...JD, Crowther MA, Bates SM, Ginsberg JS. | title=Are brand-name and generic warfarin interchangeable? Multiple n-of-1 randomized, crossover trials. | journal=An5 KB (657 words) - 23:50, 12 July 2010
- ...ulation effects of [[anisindione]], [[acenocoumarol]], [[dicumarol]] and [[warfarin]]. [[Rifampin]] increases the effect of leflunomide.1,019 bytes (134 words) - 08:28, 8 June 2009
- ...{MeSH}}</ref> Like [[warfarin]], dabigatran is given orgally, but unlike [[warfarin]] dabigatran is administered in fixed doses without the need for coagulatio ...ar AK, Mismetti P, Schellong S, Eriksson H et al.| title=Dabigatran versus warfarin in the treatment of acute venous thromboembolism. | journal=N Engl J Med |12 KB (1,732 words) - 11:47, 2 February 2023
- ...ko, Freek W.A. Verheugt, Jun Zhu, Lars Wallentin | title = Apixaban versus Warfarin in Patients with Atrial Fibrillation | journal = New England Journal of Med ...o, Freek W.A. Verheugt, Jun Zhu, Lars Wallentin | title = Apixaban versus Warfarin in Patients with Atrial Fibrillation | journal = New England Journal of M5 KB (670 words) - 11:52, 2 February 2023
- ...s SM, ''et al'' |title=Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation |journal=Circulation |vo5 KB (713 words) - 17:34, 10 February 2024
- ...te journal |author=Eckhoff CD, Didomenico RJ, Shapiro NL |title=Initiating warfarin therapy: 5 mg versus 10 mg |journal=Ann Pharmacother |volume=38 |issue=12 | ...IX||24 hours<ref name="pmid15522981"/>||[[Liver failure]], [[heparin]], [[warfarin]] therapy, [[Vitamin K]] deficiency13 KB (1,708 words) - 08:01, 12 December 2010
- ...agulant effects of [[anisindione]], [[dicumarol]], [[acenocoumarol]] and [[warfarin]]. It also decreases the absorption of the [[thyroid hormone]]s [[levothyr2 KB (204 words) - 06:35, 8 June 2009
- ...[[acenocoumarol]], [[anisindione]], [[dicumarol]], [[methotrexate]] and [[warfarin]] are increased when taken with cloxacillin.2 KB (210 words) - 06:34, 8 June 2009
- ...eSH}}</ref> Like [[warfarin]], rivaroxaban is given orgally, but unlike [[warfarin]] rivaroxaban is administered in fixed doses without the need for coagulati4 KB (500 words) - 14:12, 2 February 2023
- ...ulant]] effects of [[anisindione]], [[dicumarol]], [[acenocoumarol]] and [[warfarin]]. There is an increased risk of [[myopathy]]/[[rhaddomyolysis]] when gemf2 KB (208 words) - 09:09, 3 November 2009
- *1 to 2—Aspirin or [[Warfarin]] to INR 2.0-3.0, depending on factors such as patient preference *3 or more—Warfarin to INR 2.0-3.0 unless contraindicated (e.g., history of falls, clinically s5 KB (641 words) - 13:44, 10 April 2024
- {{r|Warfarin}}2 KB (310 words) - 12:22, 18 April 2024
- ...en responsible for [[pharmacokinetics]], writing [[TPN]] orders, modifying warfarin therapy, managing diabetes and providing diabetes education, and serving as2 KB (339 words) - 08:24, 11 April 2024
- ===Warfarin=== {{main|warfarin}}20 KB (2,687 words) - 13:56, 10 February 2015
- ...agulant effects of [[acenocoumarol]], [[anisindione]], [[dicumarol]] and [[warfarin]] are increased when taken with piperacillin. Piperacillin also increases2 KB (306 words) - 01:25, 3 June 2009
- {{r|Warfarin}}3 KB (366 words) - 12:22, 18 April 2024
- ...nsinger CM, Wan F, Yang YX, Hennessy S| title=Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk. | journal=Am J Med | year= 2010 | ...J, Higgins J |title=CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis |journal=Ge22 KB (2,960 words) - 17:35, 10 February 2024
- ...agulant effect of [[anisindione]], [[acenocoumarol]], [[dicumarol]], and [[warfarin]] and also increases the effect of [[benzodiazepine]]. Benzodiazepine relat3 KB (371 words) - 01:56, 11 September 2013
- {{r|Warfarin}}4 KB (505 words) - 16:36, 11 January 2010
- ...nt drugs including [[acenocoumarol]], [[anisindione]], [[dicumarol]] and [[warfarin]] and lessen the effects of some oral contraceptives including [[ethinyl es3 KB (365 words) - 01:25, 3 June 2009
- ...gulant effect of [[anisindione]], [[acenocoumarol]], [[dicumarol]], and [[warfarin]] and also increases the effect of [[benzodiazepine]] when taken with [[mid4 KB (448 words) - 01:55, 11 September 2013
- ...e also potential interactions with [[oral contraceptive]]s, [[digoxin]], [[warfarin]],4 KB (516 words) - 00:39, 2 February 2011
- ...Yusuf S, Eikelboom J, Oldgren J, Parekh A et al.| title=Dabigatran versus Warfarin in Patients with Atrial Fibrillation. | journal=N Engl J Med | year= 2009 ...21870978"/><br/>2011|| 18,201 patients|| [[Apixaban]] 5 mg twice daily ||[[warfarin]] (target [[International Normalized Ratio|INR]] 2.0 to 3.0; time in therap32 KB (4,336 words) - 20:38, 2 February 2015
- ...ulant effects of [[acenocoumarol]], [[anisindione]], [[dicoumarol]] and [[warfarin]]. The use of hydrocortisone with [[midodrine]] increases arterial pressur4 KB (439 words) - 01:53, 29 October 2013
- ...|author=Sands CD, Chan ES, Welty TE |title=Revisiting the significance of warfarin protein-binding displacement interactions |journal=The Annals of pharmacoth Some drug interactions with [[warfarin]] are due to changes in protein binding.<ref name="pmid12369572"/>9 KB (1,188 words) - 11:45, 2 February 2023
- ...ine]]. It "does not appear to inhibit the metabolism of drugs, including [[warfarin]], [[theophylline]], [[phenytoin]], [[diazepam]], or procainamide, by the h4 KB (517 words) - 13:22, 2 February 2023
- {{Image|Warfarin structure.jpg|right|200px|Structure of Warfarin.}} '''Warfarin''' (IUPAC name52 KB (7,136 words) - 22:53, 6 April 2014
- ...which were identified as gamma-carboxyglutamate. Prothrombin isolated from warfarin-treated cows had normal glutamate at the Gla-positions and was designated a9 KB (1,333 words) - 07:35, 9 June 2009
- ...r Hemorrhage-Related Adverse Events From Clopidogrel Plus Aspirin and From Warfarin4 KB (543 words) - 01:43, 8 May 2013
- ...ire the use of advanced [[pharmacokinetic]] principles. Examples include [[warfarin]] management, [[diabetes]] and [[hypertension]] management, [[HIV]] medicat6 KB (888 words) - 00:00, 5 March 2009
- ...r AK, Mismetti P, Schellong S, Eriksson H et al.| title=Dabigatran versus warfarin in the treatment of acute venous thromboembolism. | journal=N Engl J Med | ...r PM, Goldhaber SZ, Danielson E, ''et al'' |title=Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism |journal=N.29 KB (3,995 words) - 11:45, 2 February 2023
- ...f treatment might signal the need for continued [[anticoagulation]] with [[warfarin]] among patients with [[embolism and thrombosis]] such as a first unprovoke9 KB (1,251 words) - 13:11, 11 May 2013